Author's response: ‘Transition considerations for extended half‐life factor products’ |
| |
Authors: | S. E. Croteau E. J. Neufeld |
| |
Affiliation: | Dana Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA |
| |
Abstract: | |
| |
Keywords: | |
|
|